DIN 02339447 · ended Mar 19, 2024 · Disruption of the manufacture of the drug.
Resolved
GALANTAMINE ER
8MG · CAPSULE (EXTENDED RELEASE) · SANIS HEALTH INC
DIN 02443015 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Galantamine. Health Canada has 62 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Galantamine is classified under “ANTI-DEMENTIA DRUGS” (ATC N06DA).
Recent changes
No changes recorded yet.
Common questions
What is Galantamine used for?
A medication used to treat symptoms of mild to moderate Alzheimer's disease.
When will Galantamine be back in stock in Canada?
Galantamine has no active shortage; supply is normal per Health Canada reports.
Why is Galantamine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.